RIKEN VITAMIN, The Current Fiscal Year Ordinary Profit Revised Upward by 7%, Dividend Revised Upward by 7 yen

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Fri Feb 14, 2025 4:00 pm JST Earnings

4526 RIKEN VITAMIN CO.,LTD. 【J-GAAP】

Earnings Report

RIKEN VITAMIN CO.,LTD. <4526> [TSE Prime] announced its financial results after the market closed on February 14th (16:00). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2025 (April to December) was 8.24 billion yen, a 1.8% decrease compared to the same period last year.

However, the full-year consolidated ordinary profit has been revised upward 6.7%, from the previous forecast of 9 billion yen to 9.6 billion yen (compared to 10.2 billion yen in the previous period), and the declining rate is expected to decrease from 12.6% to 6.8%.

Based on the full-year plan announced by the company after the upward revision, our estimate of the consolidated ordinary profit for the October to March period (2H) has been revised upward 14.2%, from the previous forecast of 4.21 billion yen to 4.81 billion yen (compared to 5.07 billion yen in the same period of the previous year), and the declining rate is expected to decrease from 17.0% to 5.2%.

In light of the strong performance, the company has increased its planned annual dividend for the current fiscal year from the original plan of 81 yen to 88 yen (compared to 81 yen in the previous period).

In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit grew 8.8% from the same period last year, reaching 3.45 billion yen. However, the operating profit margin decreased from 12.5% in the same period last year to 11.4%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Dec, 2022	67,303	5,966	6,507	4,891	149.1	84.3	Feb 10, 2023	J-GAAP
Apr - Dec, 2023	69,058	7,660	8,396	6,080	185.3	81.5	Feb 9, 2024	J-GAAP
Apr - Dec, 2024	72,852	7,544	8,241	5,834	192.2	85.8	Feb 14, 2025	J-GAAP
YoY	+5.5%	-1.5%	-1.8%	-4.0%	+3.7%

Guidance Update

Second Half Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2024 Prev	45,351	3,874	4,214	4,845	162.2	40.50	Nov 13, 2024	J-GAAP
Oct - Mar, 2024 New	48,451	4,174	4,814	5,645	189.0	47.50	Feb 14, 2025	J-GAAP
Revision Rate	+6.8%	+7.7%	+14.2%	+16.5%	+16.5%

Full Year Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2025 Prev	92,500	8,500	9,000	8,100	271.1	81	May 10, 2024	J-GAAP
Mar, 2025 New	95,600	8,800	9,600	8,900	297.9	88	Feb 14, 2025	J-GAAP
Revision Rate	+3.4%	+3.5%	+6.7%	+9.9%	+9.9%

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2023	46,871	4,775	5,076	5,088	156.0	50.50	May 10, 2024	J-GAAP
Oct - Mar, 2024 Guidance	48,451	4,174	4,814	5,645	189.0	47.50	Feb 14, 2025	J-GAAP
YoY	+3.4%	-12.6%	-5.2%	+10.9%	+21.1%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2023	88,750	7,158	7,723	6,414	195.5	59	May 12, 2023	J-GAAP
Mar, 2024	91,484	9,371	10,296	8,755	268.4	81	May 10, 2024	J-GAAP
Mar, 2025 Guidance	95,600	8,800	9,600	8,900	297.9	88	Feb 14, 2025	J-GAAP
YoY	+4.5%	-6.1%	-6.8%	+1.7%	+11.0%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2023	24,445	3,064	3,176	2,413	73.5	12.5	Feb 9, 2024	J-GAAP
Jan - Mar, 2024	22,426	1,711	1,900	2,675	82.0	7.6	May 10, 2024	J-GAAP
Apr - Jun, 2024	23,626	2,522	2,927	2,370	78.1	10.7	Aug 9, 2024	J-GAAP
Jul - Sep, 2024	23,523	2,104	1,859	885	29.2	8.9	Nov 13, 2024	J-GAAP
Oct - Dec, 2024	25,703	2,918	3,455	2,579	85.0	11.4	Feb 14, 2025	J-GAAP
YoY	+5.1%	-4.8%	+8.8%	+6.9%	+15.5%